Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
NCT:NCT05295615 · RECRUITING
广告
NCT编号NCT05295615
状态RECRUITING
开始日期2023-05-01
完成时间2027-09-30
SponsorHerrick Medical LLC (INDUSTRY)
First posted
Last updated
简要摘要
An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。